• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FKRP突变小鼠中α-肌营养不良蛋白聚糖功能糖基化的恢复与肌肉再生相关。

Restoration of Functional Glycosylation of α-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle Regeneration.

作者信息

Awano Hiroyuki, Blaeser Anthony, Keramaris Elizabeth, Xu Lei, Tucker Jason, Wu Bo, Lu Pei, Lu Qi L

机构信息

McColl-Lockwood Laboratory for Muscular Dystrophy Research, Cannon Research Center, Carolinas Medical Center, Charlotte, North Carolina.

McColl-Lockwood Laboratory for Muscular Dystrophy Research, Cannon Research Center, Carolinas Medical Center, Charlotte, North Carolina.

出版信息

Am J Pathol. 2015 Jul;185(7):2025-37. doi: 10.1016/j.ajpath.2015.03.017. Epub 2015 May 12.

DOI:10.1016/j.ajpath.2015.03.017
PMID:25976249
Abstract

Mutations in fukutin-related protein (FKRP) gene are characterized with lack of functionally glycosylated α-dystroglycan (F-α-DG). Surprisingly, a few muscle fibers express strong F-α-DG. Herein, we investigated the restoration of F-α-DG in the FKRP mutant muscles and showed that the restoration of glycosylation is associated with muscle regeneration and dependent on the expression of both like-glycosyltransferase (LARGE) and partially functional FKRP. F-α-DG in the regenerating fibers reaches up to normal levels and lasts for >4 weeks, but no up-regulation of the LARGE and FKRP is detected during the regeneration process. The FKRP protein with P448L mutation is sufficient for functional glycosylation of α-DG in regenerating fibers, but not in mature fibers. Thus, factors other than FKRP enable regenerating fibers to produce functional α-DG, compensating for the defect in FKRP function. Identification of factors other than LARGE and FKRP could generate new approaches for restoration of F-α-DG in mature muscle fibers with defects in FKRP functions.

摘要

福斯素相关蛋白(FKRP)基因突变的特征是缺乏功能糖基化的α-肌营养不良蛋白(F-α-DG)。令人惊讶的是,少数肌纤维表达强F-α-DG。在此,我们研究了FKRP突变肌肉中F-α-DG的恢复情况,并表明糖基化的恢复与肌肉再生相关,且依赖于类糖基转移酶(LARGE)和部分功能性FKRP的表达。再生纤维中的F-α-DG达到正常水平并持续超过4周,但在再生过程中未检测到LARGE和FKRP的上调。具有P448L突变的FKRP蛋白足以使再生纤维中的α-DG进行功能性糖基化,但不能使成熟纤维中的α-DG进行功能性糖基化。因此,除FKRP外的其他因素使再生纤维能够产生功能性α-DG,弥补FKRP功能缺陷。鉴定除LARGE和FKRP外的其他因素可为恢复FKRP功能缺陷的成熟肌纤维中的F-α-DG产生新方法。

相似文献

1
Restoration of Functional Glycosylation of α-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle Regeneration.FKRP突变小鼠中α-肌营养不良蛋白聚糖功能糖基化的恢复与肌肉再生相关。
Am J Pathol. 2015 Jul;185(7):2025-37. doi: 10.1016/j.ajpath.2015.03.017. Epub 2015 May 12.
2
Expression of glycosylated α-dystroglycan in newborn skeletal and cardiac muscles of fukutin related protein (FKRP) mutant mice.福金相关蛋白(FKRP)突变小鼠新生骨骼肌和心肌中糖基化α- dystroglycan的表达。
Muscle Nerve. 2017 Apr;55(4):582-590. doi: 10.1002/mus.25378. Epub 2016 Dec 30.
3
Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice.功能糖基化α-肌营养不良蛋白聚糖在FKRP突变小鼠肌肉和非肌肉组织中的不同表达
PLoS One. 2018 Jan 10;13(1):e0191016. doi: 10.1371/journal.pone.0191016. eCollection 2018.
4
Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity.缺乏功能性α-肌营养不良蛋白糖基化的肌营养不良症肌肉保留再生能力。
Neuromuscul Disord. 2015 Jun;25(6):474-84. doi: 10.1016/j.nmd.2015.03.004. Epub 2015 Mar 16.
5
Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.法布瑞氏症相关蛋白对于老鼠的肌肉、大脑和眼睛发育非常重要,其突变可重现黏多糖贮积症的广泛临床表现。
Hum Mol Genet. 2010 Oct 15;19(20):3995-4006. doi: 10.1093/hmg/ddq314. Epub 2010 Jul 30.
6
Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions.腺相关病毒 9 介导的 FKRP 基因治疗恢复了 α-肌营养不良聚糖的功能糖基化,并改善了肌肉功能。
Mol Ther. 2013 Oct;21(10):1832-40. doi: 10.1038/mt.2013.156. Epub 2013 Jul 2.
7
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice.肌醇恢复功能性糖基化的α- dystroglycan 并改善 FKRP 突变型肌营养不良小鼠的肌肉功能。
Nat Commun. 2018 Aug 27;9(1):3448. doi: 10.1038/s41467-018-05990-z.
8
Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.工程化卫星细胞的自体肌肉内移植诱导外泌体介导的福库汀相关蛋白的全身表达,并在2I型肢带型肌营养不良小鼠模型中挽救疾病表型。
Hum Mol Genet. 2017 Oct 1;26(19):3682-3698. doi: 10.1093/hmg/ddx252.
9
Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.腺相关病毒介导的LARGE过表达可挽救福金相关蛋白突变的营养不良小鼠中α- dystroglycan的功能。
Hum Gene Ther Methods. 2014 Jun;25(3):187-96. doi: 10.1089/hgtb.2013.151. Epub 2014 May 2.
10
Zebrafish models for human FKRP muscular dystrophies.人类 FKRP 肌营养不良症的斑马鱼模型。
Hum Mol Genet. 2010 Feb 15;19(4):623-33. doi: 10.1093/hmg/ddp528. Epub 2009 Dec 1.

引用本文的文献

1
Ribitol treatment rescues dystroglycanopathy mice with common L276I mutation.核糖醇治疗可挽救具有常见L276I突变的肌营养不良聚糖病小鼠。
PLoS One. 2025 Aug 20;20(8):e0325239. doi: 10.1371/journal.pone.0325239. eCollection 2025.
2
Dual FKRP/FST gene therapy normalizes ambulation, increases strength, decreases pathology, and amplifies gene expression in LGMDR9 mice.双FKRP/FST基因疗法可使LGMDR9小鼠的行走能力正常化、增强力量、减少病理变化并增强基因表达。
Mol Ther. 2024 Aug 7;32(8):2604-2623. doi: 10.1016/j.ymthe.2024.06.028. Epub 2024 Jun 22.
3
Oral ribose supplementation in dystroglycanopathy: A single case study.
口服核糖补充剂治疗糖基化肌营养不良症:一项单病例研究。
JIMD Rep. 2024 Mar 4;65(3):171-181. doi: 10.1002/jmd2.12394. eCollection 2024 May.
4
Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of Interpretation.FKRP 相关糖蛋白病中聚糖蛋白和疾病表型之间的复杂性和不一致性的解析:综述和解释模型。
J Neuromuscul Dis. 2024;11(2):275-284. doi: 10.3233/JND-230205.
5
Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model.肌醇剂量依赖性地增强了肌腱蛋白聚糖的表达,并改善了肢带型肌肉营养不良 2I 模型小鼠的肌肉功能,延长了其寿命。
PLoS One. 2022 Dec 1;17(12):e0278482. doi: 10.1371/journal.pone.0278482. eCollection 2022.
6
A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy.一种用于 FKRP 相关的肌营养不良蛋白聚糖病的通用基因校正方法,以实现自体细胞治疗。
Cell Rep. 2021 Jul 13;36(2):109360. doi: 10.1016/j.celrep.2021.109360.
7
Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge.DMD 和 LGMD2I 中的回复现象及其治疗意义:在 Terrence Partridge 指导下进行的研究综述。
J Neuromuscul Dis. 2021;8(s2):S359-S367. doi: 10.3233/JND-210692.
8
Metabolomics Analysis of Skeletal Muscles from FKRP-Deficient Mice Indicates Improvement After Gene Replacement Therapy.FKRP 缺陷小鼠骨骼肌的代谢组学分析表明基因替代治疗后的改善。
Sci Rep. 2019 Jul 11;9(1):10070. doi: 10.1038/s41598-019-46431-1.
9
A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.肢带型肌营养不良 2I 模型的肌营养不良症,确定了矫正肌营养不良症相关糖蛋白病的药物化合物。
JCI Insight. 2018 Sep 20;3(18). doi: 10.1172/jci.insight.120493.
10
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice.肌醇恢复功能性糖基化的α- dystroglycan 并改善 FKRP 突变型肌营养不良小鼠的肌肉功能。
Nat Commun. 2018 Aug 27;9(1):3448. doi: 10.1038/s41467-018-05990-z.